Trump's 100 Percent Pharma Tariff to Have Twofold Impact on Indian Drugmakers
The proposed tariffs target only branded and patented medicines, leaving India’s generic exports largely unaffected. While companies making branded drugs for the US may face challenges, domestic generic producers could benefit from increased demand for affordable alternatives.
Indian Drug Makers | 29/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy